GLP-1 Agonists and HIV: Do Weight-Loss Drugs Make Sense for Your Patients?     Three GLP-1 agonist drugs (which originally had been confined to diabetes treatment) are currently FDA approved specifically for weight loss. The rapid uptake of these medications in the U.S. has naturally led to...

For all too many people living with HIV in the U.S., the prospect of facing incarceration because of their status is not an abstraction: It is a real and present danger. And in many states, it has nothing to do with science. This month, Juan Michael Porter II speaks with Joseph Cherabie, M.D.,...

Summer weather is transitioning into sweater weather in most of the U.S., and that means we -- and our patients -- are about to spend a lot more time indoors, inevitably getting exposed to numerous microbes. Accordingly, this month we're talking about vaccinations for people living with HIV: why...